Latest Safety News

NeuroScientific Biopharmaceuticals reveals compelling clinical evidence supporting its StemSmart MSC therapy for severe steroid-refractory graft versus host disease, advancing its strategic acquisition plans.

Race Oncology has successfully dosed the first patient with its RC220 and doxorubicin combination in a Phase 1 trial for advanced solid tumours, reporting no dose-limiting side effects. This milestone marks a key step in evaluating the safety and potential cardioprotective benefits of the novel therapy.

Amplia Therapeutics has announced a second confirmed complete response in its ACCENT trial for advanced pancreatic cancer, a notably rare achievement in this challenging disease.

Aurelia Metals has unveiled a robust growth strategy targeting around 40,000 tonnes of copper equivalent production by fiscal 2028, backed by a strong balance sheet and multiple development projects. The company is advancing key operations in the Cobar region while emphasizing operational discipline and sustainability.

Aquirian Limited unveils a strategic growth plan centered on its Wubin Energetics hub and proprietary Collar Keeper® technology, aiming to boost revenue and operational efficiency amid rising mining demand.

Morella Corporation has initiated a pioneering rubidium extraction study with Edith Cowan University and secured key approvals for development drilling at its Mt Edon Project, setting the stage for a maiden mineral resource estimate.

X2M Connect Limited has secured $1.95 million through a share placement and convertible note conversion, aiming to strengthen its balance sheet and accelerate growth in AI and IoT sectors.

Makilala Mining has appointed leading consultants to refine and optimise the MCB Copper-Gold Project’s mine plan and infrastructure design, aiming to enhance operational efficiency and environmental outcomes.

Bastion Minerals Limited has announced a non-renounceable pro-rata rights issue to raise approximately $677,721 at a 50% discount to the last trading price. The funds will support ongoing project evaluation and working capital needs.

INOVIQ Limited has announced a breakthrough in its cancer treatment program, with its CAR-exosome therapy killing 88% of triple negative breast and lung cancer cells in laboratory studies. This innovation could pave the way for faster, safer, and more accessible cancer therapies.

Provaris Energy and Yinson have completed the design of a groundbreaking large-scale liquid CO2 tank for maritime use and are forming a joint venture to commercialize this innovation, aiming to scale carbon capture supply chains and reduce costs.

Boss Energy has successfully met its FY25 production guidance at the Honeymoon Uranium Operation, marking a key milestone in its ramp-up phase and positioning the company for increased output and cashflow in FY26.